Lim Myong Cheol, Lee Hyun-Sung, Jung Dae Chul, Choi Ji Young, Seo Sang-Soo, Park Sang-Yoon
Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Korea.
Ann Surg Oncol. 2009 Jul;16(7):1990-6. doi: 10.1245/s10434-009-0486-5. Epub 2009 Apr 30.
The aim of this study was to assess the benefit of video-assisted thoracic surgery (VATS) in pathological diagnosis and intrathoracic cytoreduction of cardiophrenic lymph node (CPLN) and pleural metastasis on computed tomography (CT) in patients with ovarian cancer.
We reviewed a database of ovarian cancer patients who underwent VATS from June 2007 to November 2008. The criterion for suspicion of malignancy on CT was either a CPLN with short-axis dimension >5 mm or multinodular pleural thickening. Seven patients with primary ovarian cancer and five patients with recurrent ovarian cancer were identified and evaluated.
Twelve patients met the criterion for suspicious malignancy on CT, with CPLN metastasis and pleural metastasis in nine and five patients, respectively. CPLN metastasis was identified in two of four patients with primary ovarian cancer and in all five patients with recurrent ovarian cancer who had CPLN >5 mm on CT. Pleural metastasis was identified in three of five patients with suspicious pleural metastasis and in one of seven patients without suspicious pleural metastasis on preoperative CT. The median operation time for VATS was 65 min and estimated blood loss was less than 20 ml in all cases. All visible intrathoracic diseases were completely resected without major complications, and VATS did not delay planned treatment.
VATS enables the accurate pathological diagnosis and intrathoracic resection of pleural and CPLN metastasis in patients with ovarian cancer with acceptable morbidity. Further studies are needed to confirm the impact of VATS on survival in patients with ovarian cancer.
本研究旨在评估电视辅助胸腔镜手术(VATS)在卵巢癌患者的病理诊断以及对计算机断层扫描(CT)显示的心胸角淋巴结(CPLN)和胸膜转移灶进行胸腔内细胞减灭术中的益处。
我们回顾了2007年6月至2008年11月期间接受VATS的卵巢癌患者数据库。CT上怀疑恶性肿瘤的标准为短轴直径>5mm的CPLN或多结节性胸膜增厚。确定并评估了7例原发性卵巢癌患者和5例复发性卵巢癌患者。
12例患者符合CT上可疑恶性肿瘤的标准,分别有9例和5例发生CPLN转移和胸膜转移。在4例原发性卵巢癌患者中有2例发现CPLN转移,在CT上CPLN>5mm的所有5例复发性卵巢癌患者中均发现CPLN转移。在5例术前CT上可疑胸膜转移的患者中有3例发现胸膜转移,在7例术前CT上无可疑胸膜转移的患者中有1例发现胸膜转移。VATS的中位手术时间为65分钟,所有病例估计失血量均少于20ml。所有可见的胸腔内疾病均被完全切除,无重大并发症,且VATS未延误计划的治疗。
VATS能够对卵巢癌患者的胸膜和CPLN转移进行准确的病理诊断和胸腔内切除,发病率可接受。需要进一步研究以证实VATS对卵巢癌患者生存的影响。